Open AccessPrevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study
Author(s) -
Liang Du,
Yu Zhang,
Xuemei Lv,
Yuxin Duan,
Xiaoyan Shi,
Haoqiang Ji,
Ruiheng Wu,
Jia Xu,
Xu Chen,
Yang Gao,
Xiwei Lu,
Ling Zhou
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s294611
Subject(s) - tuberculosis , medicine , rifampicin , amikacin , isoniazid , ofloxacin , mycobacterium tuberculosis , drug resistance , multiple drug resistance , multi drug resistant tuberculosis , veterinary medicine , antibiotics , microbiology and biotechnology , ciprofloxacin , biology , pathology
Multidrug-resistant tuberculosis (MDR-TB) is the cause of serious health and economic burdens worldwide. The present study aimed to explore the initial and acquired drug-resistance rates among TB patients from 2012 to 2019 in Dalian, China. The effectiveness of MDR-TB prevention and control strategies were then evaluated.